Extracorporeal life support provision in COVID-19 patients - An international EuroELSO 2022 update survey
Jazyk angličtina Země Anglie, Velká Británie Médium print-electronic
Typ dokumentu časopisecké články
PubMed
36625181
PubMed Central
PMC9834627
DOI
10.1177/02676591221151034
Knihovny.cz E-zdroje
- Klíčová slova
- COVID-19, ECLS, ECMO, SARS-CoV-2, extracorporeal life support, extracorporeal membrane oxygenation,
- MeSH
- COVID-19 * epidemiologie MeSH
- dítě MeSH
- dospělí MeSH
- lidé MeSH
- mimotělní membránová oxygenace * MeSH
- pandemie MeSH
- postakutní syndrom COVID-19 MeSH
- průzkumy a dotazníky MeSH
- Check Tag
- dítě MeSH
- dospělí MeSH
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
INTRODUCTION: An analysis on the ECLS use for patients with respiratory or cardiac support in COVID-19 based on an international response to EuroELSO survey, aims to generate a more comprehensive understanding of ECLS role during the recent viral pandemic. METHODS: EuroELSO announced the survey at the 10th annual congress in London, May 2022. The survey covered 26 multiple-choice questions. RESULTS: The survey returned 69 questionnaires from 62 centers across 22 European countries and seven centers across five non-European countries. Most of the centers providing ECLS for COVID-19 patients had more than 30 runs for respiratory support since December 2019. In the same period, at least 31 runs in adult COVID-19 patients have been performed in 48 of 69 centers (69.6%). The reported pediatric data from 18 centers is limited to less than the patients per center. CONCLUSION: Majority of the COVID-19 patients received respiratory ECLS support and adult patients dominated. The indications and contraindications are broadly aligned with available guidelines. Most of the centers considered age >65 or biological age as a relative or absolute contraindication for ECLS in COVID-19. ECLS withdrawal criteria in COVID-19 are controversial because the long-term outcomes after ECLS in COVID-19 and the impact of critical illness and the impact of long-COVID are still not known.
2nd Department of Internal Cardiovascular Medicine General University Hospital Prague Czech Republic
Birmingham Women´s and Children´s NHS Foundation Trust Birmingham UK
Cardio Thoracic Surgery Department Maastricht University Medical Center Maastricht The Netherlands
Centre for Human and Applied Physiological Sciences King's College London London UK
Department of Critical Care Guy's and St Thomas' NHS Foundation Trust London UK
Department of Critical Care Royal Papworth NHS Foundation Trust Cambridge UK
Department of Internal Medicine 2 Universitätsklinikum Regensburg Regensburg Germany
Department of Perfusion University Hospital Gasthuisberg Leuven Belgium
Department of Respiratory Medicine Paracelsus Medical University Nuremberg Germany
Intensive Care Unit Maurizio Bufalini Hospital Cesena Italy
Paediatric Intensive care Leiden University Medical Center Leiden The Netherlands
Pediatric Intensive Care Unit Children's Hospital Bambino Gesù Rome Italy